RU2015138087A - The active ingredient of the drug, drug, pharmaceutical composition and method for the treatment of demyelinating diseases of a living organism, including disease prevention - Google Patents

The active ingredient of the drug, drug, pharmaceutical composition and method for the treatment of demyelinating diseases of a living organism, including disease prevention Download PDF

Info

Publication number
RU2015138087A
RU2015138087A RU2015138087A RU2015138087A RU2015138087A RU 2015138087 A RU2015138087 A RU 2015138087A RU 2015138087 A RU2015138087 A RU 2015138087A RU 2015138087 A RU2015138087 A RU 2015138087A RU 2015138087 A RU2015138087 A RU 2015138087A
Authority
RU
Russia
Prior art keywords
drug
living organism
demyelinating diseases
treatment
pharmaceutical composition
Prior art date
Application number
RU2015138087A
Other languages
Russian (ru)
Other versions
RU2631887C2 (en
Inventor
Вагиф Султанович Султанов
Тамара Валентиновна Никитина
Марина Юрьевна Ходанович
Original Assignee
Вагиф Султанович Султанов
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Вагиф Султанович Султанов filed Critical Вагиф Султанович Султанов
Priority to RU2015138087A priority Critical patent/RU2631887C2/en
Priority to PCT/RU2016/000459 priority patent/WO2017044002A1/en
Publication of RU2015138087A publication Critical patent/RU2015138087A/en
Application granted granted Critical
Publication of RU2631887C2 publication Critical patent/RU2631887C2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/765—Polymers containing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/13—Coniferophyta (gymnosperms)
    • A61K36/15—Pinaceae (Pine family), e.g. pine or cedar

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Claims (15)

1. Применение полипренолов формулы (1)1. The use of polyprenols of the formula (1)
Figure 00000001
, где n=8-20.
Figure 00000001
where n = 8-20. в качестве активного ингредиента для производства лекарственного средства для лечения демиелинизирующих заболеваний живого организма.as an active ingredient in the manufacture of a medicament for the treatment of demyelinating diseases of a living organism. 2. Применение полипренолов формулы (1)2. The use of polyprenols of the formula (1)
Figure 00000001
, где n=8-20.
Figure 00000001
where n = 8-20. в качестве активного ингредиента для производства лекарственного средства для профилактики демиелинизирующих заболеваний живого организма.as an active ingredient in the manufacture of a medicament for the prevention of demyelinating diseases of a living organism. 3. Лекарственное средство для лечения демиелинизирующих заболеваний живого организма, включая профилактику заболевания, отличающееся тем, что представляет собой полипренолы формулы (1)3. A drug for the treatment of demyelinating diseases of a living organism, including the prevention of disease, characterized in that it is a polyprenol of the formula (1)
Figure 00000001
, где n=8-20.
Figure 00000001
where n = 8-20. 4. Фармацевтическая композиция для лечения демиелинизирующих заболеваний живого организма, включая профилактику заболевания, отличающееся тем, что включает эффективное количество полипренолов формулы (1)4. The pharmaceutical composition for the treatment of demyelinating diseases of a living organism, including disease prevention, characterized in that it comprises an effective amount of polyprenols of the formula (1)
Figure 00000001
, где n=8-20.
Figure 00000001
where n = 8-20. и фармацевтически приемлемые вспомогательные вещества, включая носители, и/или растворители, добавки и/или лубриканты.and pharmaceutically acceptable excipients, including carriers, and / or solvents, additives and / or lubricants. 5. Фармацевтическая композиция по п. 4, отличающаяся тем, что выполнена в виде раствора, суспензии, капсулы, таблетки, гранулы, свечи.5. The pharmaceutical composition according to claim 4, characterized in that it is made in the form of a solution, suspension, capsule, tablet, granule, suppository. 6. Способ лечения демиелинизирующих заболеваний живого организма, включая профилактику заболевания, отличающийся тем, что в живой организм вводят эффективное количество полипренолов формулы (1)6. A method of treating demyelinating diseases of a living organism, including disease prevention, characterized in that an effective amount of polyprenols of the formula (1) is introduced into a living organism
Figure 00000002
Figure 00000002
 в виде самостоятельного препарата или в виде фармацевтической композиции, дополнительно включающей вспомогательные ингредиенты.in the form of a stand-alone preparation or in the form of a pharmaceutical composition further comprising auxiliary ingredients.
RU2015138087A 2015-09-07 2015-09-07 Active drug ingredient, drug, pharmaceutical composition and method for treatment of demyelinating diseases of living organism, including disease prevention RU2631887C2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU2015138087A RU2631887C2 (en) 2015-09-07 2015-09-07 Active drug ingredient, drug, pharmaceutical composition and method for treatment of demyelinating diseases of living organism, including disease prevention
PCT/RU2016/000459 WO2017044002A1 (en) 2015-09-07 2016-07-20 Active ingredient of a drug and a drug, a pharmaceutical composition and a method for treating demyelinating diseases of the human body, which includes prophylaxis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2015138087A RU2631887C2 (en) 2015-09-07 2015-09-07 Active drug ingredient, drug, pharmaceutical composition and method for treatment of demyelinating diseases of living organism, including disease prevention

Publications (2)

Publication Number Publication Date
RU2015138087A true RU2015138087A (en) 2017-03-14
RU2631887C2 RU2631887C2 (en) 2017-09-28

Family

ID=58240362

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2015138087A RU2631887C2 (en) 2015-09-07 2015-09-07 Active drug ingredient, drug, pharmaceutical composition and method for treatment of demyelinating diseases of living organism, including disease prevention

Country Status (2)

Country Link
RU (1) RU2631887C2 (en)
WO (1) WO2017044002A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2761617C2 (en) * 2019-10-04 2021-12-13 Жаудат Гафурович Умеров Complex of myelin lipids of central and peripheral nervous system of animals for treatment and prevention of neurodegenerative demyelinating disorders and methods for its application

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2444356A (en) * 1943-05-12 1948-06-29 Richard W Luce Retrodirective light-reflecting device
RU2252026C1 (en) * 2003-10-29 2005-05-20 Рощин Виктор Иванович Method for stimulating the processes of natural hepatic regeneration
AU2007224438B2 (en) * 2006-03-15 2012-07-26 Biovitrum Ab (Publ) Autoimmune conditions and NADPH oxidase defects
RU2327448C1 (en) * 2007-05-23 2008-06-27 Виктор Иванович Рощин Medicinal agent for ethyl alcohol and/or narcotic addiction treatment, parmaceutical composition, active ingredient of pharmaceutical composition, method of ethyl alcohol and/or narcotic addiction treatment for alcoholics' and/or narcotists' psychosomatic and neurological complication treatment
RU2327480C1 (en) * 2007-05-23 2008-06-27 Виктор Иванович Рощин Active ingredient of medicinal agent, medicinal agent, pharmaceutical conposition and method of dement syndrome treatment

Also Published As

Publication number Publication date
RU2631887C2 (en) 2017-09-28
WO2017044002A1 (en) 2017-03-16

Similar Documents

Publication Publication Date Title
RU2018110647A (en) Aryl, heteroaryl and heterocyclic compounds for the treatment of diseases
WO2016042163A3 (en) Ophthalmic drug compositions
EA201101518A1 (en) PHARMACEUTICAL COMPOSITION FOR USE IN MEDICAL AND VETERINARY OPHTHALMOLOGY
EA201690069A1 (en) THE USE OF HIGH DOSE PRIDOPIDINE FOR THE TREATMENT OF THE HANTINGTON'S DISEASE
EA201992162A1 (en) COMPOSITIONS BASED ON NIRAPARIB
RU2015134581A (en) NITROXIL DONORS WITH IMPROVED THERAPEUTIC INDEX
EA201300314A8 (en) COMPOSITIONS AND MEDICINES FOR THE TREATMENT OF EYE DISEASES, DEVICE CONTAINING COMPOSITIONS AND MEDICINES
EA202190510A1 (en) A NEW DRUG FOR THE TREATMENT OF INFLAMMATORY INTESTINAL DISEASE
HRP20210418T1 (en) Syd985 treatment of t-dm1 refractory cancer patients
EA201792565A1 (en) BISAMID DERIVATIVE OF DICARBONIC ACID AS A MEANS STIMULATING TISSUE REGENERATION AND RESTORING DECREASED TISSUE FUNCTIONS
RU2015138087A (en) The active ingredient of the drug, drug, pharmaceutical composition and method for the treatment of demyelinating diseases of a living organism, including disease prevention
RU2015111491A (en) COMBINATION OF THE MACROCYCLIC HCV PROTEASE INHIBITOR, HCV NON-NUCLEOSIDE INHIBITOR AND RITONAVIR
RU2017140348A (en) Drug for the treatment of respiratory diseases in horses and method for its use
RU2015131803A (en) GLUTARIMID DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS FOR PRODUCING THEM
JP6100510B2 (en) Anti-cold medicine
MY191983A (en) Pharmaceutical formulations comprising sodium palmitoyl-l-prolyl-l-prolyl-glycyl-l-tyrosinate and methods for preparing the same
RU2015131801A (en) GLUTARIMID DERIVATIVES, THEIR APPLICATION, PHARMACEUTICAL COMPOSITION BASED ON THEM, METHODS FOR PRODUCING THEM
RU2022102195A (en) NEW METHODS FOR THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS
RU2490018C1 (en) Method of dog's hepatosis therapy
MD3439637T2 (en) Process for mesalazine solid formulations
MX2018013474A (en) Carboxylic acids for early childhood application.
RU2021102899A (en) COMPOUNDS SUITABLE FOR HIV THERAPY
RU2016143153A (en) COMBINATIONS OF ANTI-CANCER MEDICINES
RU2021106073A (en) PHARMACEUTICAL COMPOUNDS
EA201690788A1 (en) PHARMACEUTICAL MEDICINE FORMS CONTAINING SODIUM-1- [6- (MORFOLIN-4-IL) Pyrimidin-4-IL] -4- (1H-1,2,3-TRIAZOL-1-IL) -1H-Pyrazole-5- OLAT